Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Cerono G, Cree BAC, Hauser SL, Baranzini SE. Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence". Ann Neurol. 2026 Feb; 99(2):553.

2026
https://researcherprofiles.org/profile/755918418
41673521

Cerono G, Cree BAC, Hauser SL, Baranzini SE